Overview
Two-year advanced fellowship (about 80% research, 20% clinical) in lung cancer care, clinical trials and translational research within the Dana-Farber Brigham Cancer Center and Harvard Medical School network; fellows receive a Dana-Farber Brigham certificate.
The programme
- Training type
- Clinical + research
- Duration
- 2 years
- Start
- July 2027 (upon acceptance)
- Positions
- Not stated on official page
- Accreditation
- Non-ACGME advanced fellowship (Dana-Farber Brigham certificate)
- Department
- Not stated on official page
Eligibility and visa
- Eligibility
- Completed training in medical oncology (minimum 2 years) or hematology/oncology (minimum 3 years); eligible for a limited or permanent Massachusetts medical licence; interest in lung cancer.
- International applicants
- Yes - open to international medical graduates; preference for candidates with a current visa or visa application in process and partial scholarship funding
- Visa support
- Not stated on official page
- Licence requirement
- Limited or permanent Massachusetts medical licence; USMLE/MCCQE licensing examinations completed or in progress
How to apply
- Deadline
- November 13, 2026
- Application method
- Application statement (max 3 pages), CV and three letters of recommendation to the Lowe Center for Thoracic Oncology administrative director
Funding
- Funding
- Paid at PGY6 (year 1) and PGY7 (year 2) levels with subsidised health insurance